Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2.
Higuchi Y, Suzuki T, Arimori T, Ikemura N, Mihara E, Kirita Y, Ohgitani E, Mazda O, Motooka D, Nakamura S, Sakai Y, Itoh Y, Sugihara F, Matsuura Y, Matoba S, Okamoto T, Takagi J, Hoshino A.
Higuchi Y, et al. Among authors: hoshino a.
Nat Commun. 2021 Jun 21;12(1):3802. doi: 10.1038/s41467-021-24013-y.
Nat Commun. 2021.
PMID: 34155214
Free PMC article.